HomeSVA • NASDAQ
add
Sinovac Biotech Ltd
Previous close
$6.47
Year range
$22.40 - $28.18
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 153.93M | 9.77% |
Operating expense | 204.29M | -55.98% |
Net income | -58.42M | 68.48% |
Net profit margin | -37.95 | 71.28% |
Earnings per share | — | — |
EBITDA | -18.18M | 96.36% |
Effective tax rate | -155.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.22B | -0.79% |
Total assets | 13.66B | -3.23% |
Total liabilities | 1.64B | 16.64% |
Total equity | 12.02B | — |
Shares outstanding | 99.64M | — |
Price to book | 0.07 | — |
Return on assets | -0.86% | — |
Return on capital | -0.95% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -58.42M | 68.48% |
Cash from operations | 71.99M | 284.78% |
Cash from investing | -96.58M | 91.12% |
Cash from financing | -146.61M | -15.85% |
Net change in cash | -185.73M | 85.61% |
Free cash flow | -26.02M | 92.76% |
About
CEO
Founded
2001
Website
Employees
3,037